Gabanti, E., Bruno, F., Lilleri, D., Fornara, C., Zelini, P., Cane, I., . . . Gerna, G. (2014). Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Gabanti, Elisa, et al. Human Cytomegalovirus (HCMV)-specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-organ Transplant Recipients. Public Library of Science (PLoS), 2014.
Cita MLA (8a ed.)Gabanti, Elisa, et al. Human Cytomegalovirus (HCMV)-specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-organ Transplant Recipients. Public Library of Science (PLoS), 2014.